查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513262

2024 年治療性血漿交換全球市場報告

Therapeutic Plasma Exchange Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

治療性血漿交換市場規模預計在未來幾年將強勁成長。 2028年，這一數字將以9.6%的複合年成長率成長至21.2億美元。預測期內的預期成長受到多種因素的推動，包括老年人口的成長、臨床證據和指南的可用性、監管環境、醫院基礎設施和醫療保健投資的增加、醫療保健支出趨勢以及不斷變化的報銷政策。預計是由於因素造成的。在此期間預計的主要趨勢包括個人化治療、將自動化整合到醫療保健實踐中、相關人員之間的協作舉措以及遠端醫療服務的整合。

血液疾病的日益普及將推動未來幾年治療性血漿交換市場的擴大。血液疾病（血液疾病）包括影響血液和造血組織（例如骨髓、淋巴結和脾臟）的疾病。這些疾病的增加是由於遺傳傾向、環境影響和生活方式改變等因素所造成的。治療性血漿置換（TPE）通過去除血漿中的致病物質（例如自體免疫溶血性貧血中的自身抗體和血栓性血小板低下紫斑症。例如，根據美國專業組織白血病和淋巴瘤協會的數據，2023年8月，骨髓瘤診斷數量預計將從2021年的34,920例增加到2023年的35,730例，增加約2.3%。因此，血液疾病的高盛行率正在推動治療性血漿置換市場的成長。

治療性血漿交換市場的主要參與者專注於開發自動血漿交換系統等先進產品，以提高治療準確性、提高工作流程效率並簡化治療設定和管理。自動血漿交換系統是醫療設備，旨在以受控且高效的方式執行治療性血漿交換 (TPE) 程序。例如，2021 年 5 月，美國醫療保健公司 Baxter International Inc. 推出了 PrisMax 2 系統，旨在透過去除血液中的有害物質來促進患者和醫院的重症加護。該系統解決了加護病房(ICU) 的關鍵挑戰，提供操作簡單性、智慧效率和資料主導的見解。該系統簡化了連續腎臟替代療法 (CRRT) 和其他體外治療的複雜性，並改善了從設置到實施的治療管理。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球治療性血漿交換市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球治療性血漿交換市場表現：規模與成長，2018-2023 年
  • 全球治療性血漿交換市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球治療性血漿交換市場：按類型、表現和預測，2018-2023、2023-2028、2033
  • 治療性血漿置換（TPE）
  • 雙重過濾血漿置換術 (DFPP)
  • 全球治療性血漿置換市場（按適應症、表現和預測），2018-2023、2023-2028、2033
  • 神經系統疾病
  • 血液疾病
  • 腎臟疾病
  • 代謝紊亂
  • 其他適應症
  • 全球治療性血漿交換市場：按技術、性能和預測分類，2018-2023、2023-2028、2033
  • 離心
  • 膜分離
  • 全球治療性血漿交換市場：按最終用戶、績效和預測，2018-2023、2023-2028、2033
  • 血液採集中心
  • 醫院和診所
  • 輸血中心
  • 其他最終用戶

第 7 章 區域/國家分析

  • 全球治療性血漿交換市場：按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球治療性血漿交換市場：依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 治療性血漿置換市場：競爭格局
  • 治療性血漿交換市場：公司簡介
    • Medica SpA
    • Fresenius SE and Co. KGaA
    • Medtronic Plc.
    • Asahi Kasei Corporation
    • Toray Industries Inc.

第31章 其他重大及創新企業

  • Baxter International Inc.
  • B Braun Melsungen AG
  • Terumo Corporation
  • Kaneka Corporation
  • Charles River Laboratories
  • Octapharma AG
  • Spectral Medical Inc.
  • Nikkiso Co. Ltd.
  • Haemonetics Corporation
  • Miltenyi Biotec Technology And Trading Co. Ltd.
  • Macopharma SA
  • Cerus Corporation
  • Apellis Pharmaceuticals Inc.
  • ImmunoTek Bio Centers LLC
  • CytoSorbents Corporation

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18249

Therapeutic plasma exchange (TPE) is a medical intervention utilized in the treatment of specific autoimmune diseases and other medical conditions. In this procedure, blood is extracted from the body, the plasma component (the fluid part of blood) is separated from the blood cells, and the blood cells are subsequently reintroduced into the body, often after being mixed with a replacement fluid. This method aids in eliminating harmful substances from the bloodstream, such as autoantibodies or toxins, which are implicated in various diseases.

The primary modalities of therapeutic plasma exchange include therapeutic plasma exchange (TPE) and double-filtered plasmapheresis (DFPP). Therapeutic Plasma Exchange (TPE) is a clinical process that involves removing plasma from the blood and substituting it with a replacement fluid, facilitating the elimination of detrimental substances or excess components. This procedure finds application in diverse medical conditions such as neurological disorders, hematological disorders, renal disorders, metabolic disorders, among others. Various technologies, including centrifugation and membrane separation, are employed in this process, catering to a range of end users such as blood collection centers, hospitals and clinics, transfusion centers, and others.

The therapeutic plasma exchange market research report is one of a series of new reports from The Business Research Company that provides therapeutic plasma exchange market statistics, including therapeutic plasma exchange industry global market size, regional shares, competitors with a therapeutic plasma exchange market share, detailed therapeutic plasma exchange market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic plasma exchange industry. This therapeutic plasma exchange market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The therapeutic plasma exchange market size has grown strongly in recent years. It will grow from $1.35 billion in 2023 to $1.47 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth observed in the historic period can be credited to several factors, including the rise of immunological diseases, advancements in technology, heightened awareness and education, expanded indications for therapeutic interventions, and a deeper understanding of the underlying pathophysiology.

The therapeutic plasma exchange market size is expected to see strong growth in the next few years. It will grow to $2.12 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth in the forecast period is expected to stem from various factors such as the increasing geriatric population, the availability of clinical evidence and guidelines, the regulatory landscape, enhancements in hospital infrastructure and healthcare investments, healthcare expenditure trends, and evolving reimbursement policies. Major trends expected during this period encompass personalized therapies, the integration of automation into healthcare practices, collaborative initiatives among stakeholders, and the integration of telemedicine services.

The increasing prevalence of hematological disorders is poised to drive the expansion of the therapeutic plasma exchange market in the future. Hematological disorders, or blood disorders, encompass medical conditions affecting blood and blood-forming tissues such as bone marrow, lymph nodes, and spleen. The rise in these disorders is attributed to factors such as genetic predispositions, environmental influences, and changes in lifestyle. Therapeutic plasma exchange (TPE) is employed in managing hematological disorders by removing pathogenic substances from the plasma, such as autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, thus alleviating disease severity and enhancing patient outcomes. For example, in August 2023, as per the Leukemia and Lymphoma Society, a US-based professional organization, the projected number of myeloma diagnoses is expected to increase by approximately 2.3% from 2021 to 2023, rising from 34,920 to 35,730, respectively. Hence, the high prevalence of hematological disorders is fueling the growth of the therapeutic plasma exchange market.

Key players in the therapeutic plasma exchange market are concentrating on developing advanced products, such as automated plasma exchange systems, to enhance treatment precision, boost workflow efficiency, and simplify therapy setup and administration. Automated plasma exchange systems are medical devices engineered to perform therapeutic plasma exchange (TPE) procedures in a controlled and efficient manner. For instance, in May 2021, Baxter International Inc., a US-based healthcare company, introduced the PrisMax 2 system, an automated plasma exchange system aimed at advancing critical care delivery in patients and hospitals by eliminating harmful substances from the blood. This system addresses critical challenges in the intensive care unit (ICU), offering operational ease, intelligent efficiencies, and data-driven insights. It simplifies the complexities of delivering continuous renal replacement therapy (CRRT) and other extracorporeal therapies, improving therapy management from setup to delivery.

In April 2021, Terumo Blood and Cell Technologies, a US-based medical equipment company, partnered with CSL Plasma to introduce a new plasma collection platform at CSL Plasma U.S. collection centers. This collaboration aims to enhance the efficiency and safety of plasma collection, a vital step in producing life-saving therapies for patients with various serious and rare diseases. CSL Plasma, a US-based plasmapheresis company, offers therapeutic plasma exchange services as part of its plasma collection process at its centers.

Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.

North America was the largest region in the therapeutic plasma exchange market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the therapeutic plasma exchange market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The therapeutic plasma exchange market consists of revenues earned by entities by providing services such as patient evaluation, treatment planning, medical monitoring, and plasma separation. The market value includes the value of related goods sold by the service provider or included within the service offering. The therapeutic plasma exchange market also includes the sale of plasma separators, replacement fluids, anticoagulants, catheters and access devices, disposable consumables, and monitoring equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Therapeutic Plasma Exchange Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on therapeutic plasma exchange market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for therapeutic plasma exchange? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The therapeutic plasma exchange market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Therapeutic Plasma Exchange (TPE); Double Filtered Plasmapheresis (DFPP)
  • 2) By Indication: Neurological Disorders; Hematological Disorders; Renal Disorders; Metabolic Disorders; Other Indications
  • 3) By Technology: Centrifugation; Membrane Separation
  • 4) By End User: Blood Collection Centers; Hospitals And Clinics; Transfusion Centers; Other End Users
  • Companies Mentioned: Medica S.p.A.; Fresenius SE and Co. KGaA; Medtronic Plc.; Asahi Kasei Corporation; Toray Industries Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Therapeutic Plasma Exchange Market Characteristics

3. Therapeutic Plasma Exchange Market Trends And Strategies

4. Therapeutic Plasma Exchange Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Therapeutic Plasma Exchange Market Size and Growth

  • 5.1. Global Therapeutic Plasma Exchange Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Therapeutic Plasma Exchange Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Therapeutic Plasma Exchange Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Therapeutic Plasma Exchange Market Segmentation

  • 6.1. Global Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Therapeutic Plasma Exchange (TPE)
  • Double Filtered Plasmapheresis (DFPP)
  • 6.2. Global Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Neurological Disorders
  • Hematological Disorders
  • Renal Disorders
  • Metabolic Disorders
  • Other Indications
  • 6.3. Global Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Centrifugation
  • Membrane Separation
  • 6.4. Global Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Blood Collection Centers
  • Hospitals And Clinics
  • Transfusion Centers
  • Other End Users

7. Therapeutic Plasma Exchange Market Regional And Country Analysis

  • 7.1. Global Therapeutic Plasma Exchange Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Therapeutic Plasma Exchange Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Therapeutic Plasma Exchange Market

  • 8.1. Asia-Pacific Therapeutic Plasma Exchange Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Therapeutic Plasma Exchange Market

  • 9.1. China Therapeutic Plasma Exchange Market Overview
  • 9.2. China Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Therapeutic Plasma Exchange Market

  • 10.1. India Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Therapeutic Plasma Exchange Market

  • 11.1. Japan Therapeutic Plasma Exchange Market Overview
  • 11.2. Japan Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Therapeutic Plasma Exchange Market

  • 12.1. Australia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Therapeutic Plasma Exchange Market

  • 13.1. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Therapeutic Plasma Exchange Market

  • 14.1. South Korea Therapeutic Plasma Exchange Market Overview
  • 14.2. South Korea Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Therapeutic Plasma Exchange Market

  • 15.1. Western Europe Therapeutic Plasma Exchange Market Overview
  • 15.2. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Therapeutic Plasma Exchange Market

  • 16.1. UK Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Therapeutic Plasma Exchange Market

  • 17.1. Germany Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Therapeutic Plasma Exchange Market

  • 18.1. France Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Therapeutic Plasma Exchange Market

  • 19.1. Italy Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Therapeutic Plasma Exchange Market

  • 20.1. Spain Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Therapeutic Plasma Exchange Market

  • 21.1. Eastern Europe Therapeutic Plasma Exchange Market Overview
  • 21.2. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Therapeutic Plasma Exchange Market

  • 22.1. Russia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Therapeutic Plasma Exchange Market

  • 23.1. North America Therapeutic Plasma Exchange Market Overview
  • 23.2. North America Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Therapeutic Plasma Exchange Market

  • 24.1. USA Therapeutic Plasma Exchange Market Overview
  • 24.2. USA Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Therapeutic Plasma Exchange Market

  • 25.1. Canada Therapeutic Plasma Exchange Market Overview
  • 25.2. Canada Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Therapeutic Plasma Exchange Market

  • 26.1. South America Therapeutic Plasma Exchange Market Overview
  • 26.2. South America Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Therapeutic Plasma Exchange Market

  • 27.1. Brazil Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Therapeutic Plasma Exchange Market

  • 28.1. Middle East Therapeutic Plasma Exchange Market Overview
  • 28.2. Middle East Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Therapeutic Plasma Exchange Market

  • 29.1. Africa Therapeutic Plasma Exchange Market Overview
  • 29.2. Africa Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Therapeutic Plasma Exchange Market Competitive Landscape And Company Profiles

  • 30.1. Therapeutic Plasma Exchange Market Competitive Landscape
  • 30.2. Therapeutic Plasma Exchange Market Company Profiles
    • 30.2.1. Medica S.p.A.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Fresenius SE and Co. KGaA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic Plc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Asahi Kasei Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Toray Industries Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Therapeutic Plasma Exchange Market Other Major And Innovative Companies

  • 31.1. Baxter International Inc.
  • 31.2. B Braun Melsungen AG
  • 31.3. Terumo Corporation
  • 31.4. Kaneka Corporation
  • 31.5. Charles River Laboratories
  • 31.6. Octapharma AG
  • 31.7. Spectral Medical Inc.
  • 31.8. Nikkiso Co. Ltd.
  • 31.9. Haemonetics Corporation
  • 31.10. Miltenyi Biotec Technology And Trading Co. Ltd.
  • 31.11. Macopharma SA
  • 31.12. Cerus Corporation
  • 31.13. Apellis Pharmaceuticals Inc.
  • 31.14. ImmunoTek Bio Centers LLC
  • 31.15. CytoSorbents Corporation

32. Global Therapeutic Plasma Exchange Market Competitive Benchmarking

33. Global Therapeutic Plasma Exchange Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Therapeutic Plasma Exchange Market

35. Therapeutic Plasma Exchange Market Future Outlook and Potential Analysis

  • 35.1 Therapeutic Plasma Exchange Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Therapeutic Plasma Exchange Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Therapeutic Plasma Exchange Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer